nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—CRABP1—The citric acid (TCA) cycle and respiratory electron transport—OGDH—primary biliary cirrhosis	0.00406	0.00931	CbGpPWpGaD
Alitretinoin—CRABP2—The citric acid (TCA) cycle and respiratory electron transport—OGDH—primary biliary cirrhosis	0.00406	0.00931	CbGpPWpGaD
Alitretinoin—CRABP1—The citric acid (TCA) cycle and respiratory electron transport—PDHX—primary biliary cirrhosis	0.00362	0.0083	CbGpPWpGaD
Alitretinoin—CRABP2—The citric acid (TCA) cycle and respiratory electron transport—PDHX—primary biliary cirrhosis	0.00362	0.0083	CbGpPWpGaD
Alitretinoin—ABCB1—Abacavir transmembrane transport—ABCG2—primary biliary cirrhosis	0.00344	0.00789	CbGpPWpGaD
Alitretinoin—CRABP2—The citric acid (TCA) cycle and respiratory electron transport—DLAT—primary biliary cirrhosis	0.0034	0.0078	CbGpPWpGaD
Alitretinoin—CRABP1—The citric acid (TCA) cycle and respiratory electron transport—DLAT—primary biliary cirrhosis	0.0034	0.0078	CbGpPWpGaD
Alitretinoin—RXRA—Pyruvate metabolism and Citric Acid (TCA) cycle—OGDH—primary biliary cirrhosis	0.00317	0.00727	CbGpPWpGaD
Alitretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—RPS6KB1—primary biliary cirrhosis	0.00302	0.00694	CbGpPWpGaD
Alitretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—primary biliary cirrhosis	0.00289	0.00664	CbGpPWpGaD
Alitretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—primary biliary cirrhosis	0.00289	0.00664	CbGpPWpGaD
Alitretinoin—RXRA—Pyruvate metabolism and Citric Acid (TCA) cycle—PDHX—primary biliary cirrhosis	0.00282	0.00648	CbGpPWpGaD
Alitretinoin—ABCB1—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00277	0.00637	CbGpPWpGaD
Alitretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—RPS6KB1—primary biliary cirrhosis	0.00277	0.00635	CbGpPWpGaD
Alitretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—RPS6KB1—primary biliary cirrhosis	0.00271	0.00622	CbGpPWpGaD
Alitretinoin—RXRA—Pyruvate metabolism and Citric Acid (TCA) cycle—DLAT—primary biliary cirrhosis	0.00265	0.00609	CbGpPWpGaD
Alitretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—RPS6KB1—primary biliary cirrhosis	0.0026	0.00597	CbGpPWpGaD
Alitretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—RPS6KB1—primary biliary cirrhosis	0.0026	0.00597	CbGpPWpGaD
Alitretinoin—RXRA—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.00229	0.00526	CbGpPWpGaD
Alitretinoin—Lymphadenopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00207	0.00367	CcSEcCtD
Alitretinoin—Lymphadenopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00207	0.00367	CcSEcCtD
Alitretinoin—Blood alkaline phosphatase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00203	0.0036	CcSEcCtD
Alitretinoin—Blood alkaline phosphatase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00203	0.0036	CcSEcCtD
Alitretinoin—Photosensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00201	0.00357	CcSEcCtD
Alitretinoin—Photosensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00201	0.00357	CcSEcCtD
Alitretinoin—Deafness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00197	0.0035	CcSEcCtD
Alitretinoin—Deafness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00197	0.0035	CcSEcCtD
Alitretinoin—ABCB1—Abacavir transport and metabolism—ABCG2—primary biliary cirrhosis	0.00197	0.00453	CbGpPWpGaD
Alitretinoin—Gastrointestinal haemorrhage—Colchicine—primary biliary cirrhosis	0.00197	0.00349	CcSEcCtD
Alitretinoin—Cardiac failure congestive—Ursodeoxycholic acid—primary biliary cirrhosis	0.00195	0.00345	CcSEcCtD
Alitretinoin—Cardiac failure congestive—Chenodeoxycholic acid—primary biliary cirrhosis	0.00195	0.00345	CcSEcCtD
Alitretinoin—RXRA—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.00193	0.00443	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.0019	0.00436	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.0019	0.00436	CbGpPWpGaD
Alitretinoin—Renal impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00186	0.00329	CcSEcCtD
Alitretinoin—Renal impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00186	0.00329	CcSEcCtD
Alitretinoin—Blood creatinine increased—Colchicine—primary biliary cirrhosis	0.00184	0.00327	CcSEcCtD
Alitretinoin—Dehydration—Colchicine—primary biliary cirrhosis	0.00183	0.00324	CcSEcCtD
Alitretinoin—Arthritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00182	0.00322	CcSEcCtD
Alitretinoin—Arthritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00182	0.00322	CcSEcCtD
Alitretinoin—Cardiac failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.00181	0.00321	CcSEcCtD
Alitretinoin—Cardiac failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.00181	0.00321	CcSEcCtD
Alitretinoin—RXRA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—CTGF—primary biliary cirrhosis	0.00181	0.00415	CbGpPWpGaD
Alitretinoin—Cerebrovascular accident—Ursodeoxycholic acid—primary biliary cirrhosis	0.0018	0.0032	CcSEcCtD
Alitretinoin—Cerebrovascular accident—Chenodeoxycholic acid—primary biliary cirrhosis	0.0018	0.0032	CcSEcCtD
Alitretinoin—RXRG—a6b1 and a6b4 Integrin signaling—RPS6KB1—primary biliary cirrhosis	0.00178	0.00409	CbGpPWpGaD
Alitretinoin—Gastrointestinal haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.00177	0.00313	CcSEcCtD
Alitretinoin—Gastrointestinal haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.00177	0.00313	CcSEcCtD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—PPARGC1A—primary biliary cirrhosis	0.00172	0.00394	CbGpPWpGaD
Alitretinoin—Face oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00171	0.00302	CcSEcCtD
Alitretinoin—Face oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00171	0.00302	CcSEcCtD
Alitretinoin—RXRB—a6b1 and a6b4 Integrin signaling—RPS6KB1—primary biliary cirrhosis	0.00168	0.00385	CbGpPWpGaD
Alitretinoin—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00165	0.00294	CcSEcCtD
Alitretinoin—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00165	0.00294	CcSEcCtD
Alitretinoin—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00291	CcSEcCtD
Alitretinoin—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00291	CcSEcCtD
Alitretinoin—Abdominal discomfort—Colchicine—primary biliary cirrhosis	0.00163	0.00289	CcSEcCtD
Alitretinoin—RXRA—REV-ERBA represses gene expression—PPARGC1A—primary biliary cirrhosis	0.0016	0.00367	CbGpPWpGaD
Alitretinoin—Neutropenia—Colchicine—primary biliary cirrhosis	0.00159	0.00282	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.00158	0.00363	CbGpPWpGaD
Alitretinoin—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00156	0.00277	CcSEcCtD
Alitretinoin—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00156	0.00277	CcSEcCtD
Alitretinoin—RXRA—RORA activates circadian gene expression—PPARGC1A—primary biliary cirrhosis	0.00155	0.00356	CbGpPWpGaD
Alitretinoin—Asthma—Ursodeoxycholic acid—primary biliary cirrhosis	0.00153	0.00271	CcSEcCtD
Alitretinoin—Asthma—Chenodeoxycholic acid—primary biliary cirrhosis	0.00153	0.00271	CcSEcCtD
Alitretinoin—Dysphagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00153	0.00271	CcSEcCtD
Alitretinoin—Dysphagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00153	0.00271	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.00152	0.00348	CbGpPWpGaD
Alitretinoin—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.00152	0.00348	CbGpPWpGaD
Alitretinoin—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0015	0.00265	CcSEcCtD
Alitretinoin—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0015	0.00265	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.00148	0.00263	CcSEcCtD
Alitretinoin—Stomatitis—Colchicine—primary biliary cirrhosis	0.00148	0.00262	CcSEcCtD
Alitretinoin—Abdominal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00146	0.0026	CcSEcCtD
Alitretinoin—Abdominal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00146	0.0026	CcSEcCtD
Alitretinoin—Haematuria—Colchicine—primary biliary cirrhosis	0.00144	0.00256	CcSEcCtD
Alitretinoin—Dysuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00143	0.00253	CcSEcCtD
Alitretinoin—Dysuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00143	0.00253	CcSEcCtD
Alitretinoin—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00142	0.00252	CcSEcCtD
Alitretinoin—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00142	0.00252	CcSEcCtD
Alitretinoin—Agranulocytosis—Colchicine—primary biliary cirrhosis	0.00141	0.00251	CcSEcCtD
Alitretinoin—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00141	0.0025	CcSEcCtD
Alitretinoin—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00141	0.0025	CcSEcCtD
Alitretinoin—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00139	0.00247	CcSEcCtD
Alitretinoin—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00139	0.00247	CcSEcCtD
Alitretinoin—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00139	0.00246	CcSEcCtD
Alitretinoin—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00139	0.00246	CcSEcCtD
Alitretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—primary biliary cirrhosis	0.00139	0.00318	CbGpPWpGaD
Alitretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—primary biliary cirrhosis	0.00139	0.00318	CbGpPWpGaD
Alitretinoin—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00138	0.00245	CcSEcCtD
Alitretinoin—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00138	0.00245	CcSEcCtD
Alitretinoin—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00243	CcSEcCtD
Alitretinoin—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00243	CcSEcCtD
Alitretinoin—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00241	CcSEcCtD
Alitretinoin—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00241	CcSEcCtD
Alitretinoin—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00241	CcSEcCtD
Alitretinoin—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00241	CcSEcCtD
Alitretinoin—Depression—Ursodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00241	CcSEcCtD
Alitretinoin—Depression—Chenodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00241	CcSEcCtD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—RPS6KB1—primary biliary cirrhosis	0.00136	0.00311	CbGpPWpGaD
Alitretinoin—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.00135	0.0024	CcSEcCtD
Alitretinoin—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.00134	0.00238	CcSEcCtD
Alitretinoin—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.00134	0.00238	CcSEcCtD
Alitretinoin—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.00134	0.00237	CcSEcCtD
Alitretinoin—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.00134	0.00237	CcSEcCtD
Alitretinoin—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00133	0.00237	CcSEcCtD
Alitretinoin—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00133	0.00237	CcSEcCtD
Alitretinoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.00133	0.00305	CbGpPWpGaD
Alitretinoin—RXRA—Recycling of bile acids and salts—ALB—primary biliary cirrhosis	0.00132	0.00304	CbGpPWpGaD
Alitretinoin—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00132	0.00235	CcSEcCtD
Alitretinoin—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00132	0.00235	CcSEcCtD
Alitretinoin—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00132	0.00235	CcSEcCtD
Alitretinoin—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00132	0.00235	CcSEcCtD
Alitretinoin—Sweating—Ursodeoxycholic acid—primary biliary cirrhosis	0.0013	0.00231	CcSEcCtD
Alitretinoin—Sweating—Chenodeoxycholic acid—primary biliary cirrhosis	0.0013	0.00231	CcSEcCtD
Alitretinoin—RXRA—PPARA activates gene expression—ABCB4—primary biliary cirrhosis	0.0013	0.00298	CbGpPWpGaD
Alitretinoin—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.0013	0.0023	CcSEcCtD
Alitretinoin—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.0013	0.0023	CcSEcCtD
Alitretinoin—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00128	0.00228	CcSEcCtD
Alitretinoin—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00128	0.00228	CcSEcCtD
Alitretinoin—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00128	0.00227	CcSEcCtD
Alitretinoin—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00128	0.00227	CcSEcCtD
Alitretinoin—RXRA—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.00127	0.00292	CbGpPWpGaD
Alitretinoin—Eye disorder—Colchicine—primary biliary cirrhosis	0.00127	0.00225	CcSEcCtD
Alitretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCB4—primary biliary cirrhosis	0.00127	0.00292	CbGpPWpGaD
Alitretinoin—RXRA—The citric acid (TCA) cycle and respiratory electron transport—OGDH—primary biliary cirrhosis	0.00123	0.00282	CbGpPWpGaD
Alitretinoin—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00218	CcSEcCtD
Alitretinoin—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00218	CcSEcCtD
Alitretinoin—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.00122	0.00217	CcSEcCtD
Alitretinoin—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.00122	0.00217	CcSEcCtD
Alitretinoin—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00121	0.00215	CcSEcCtD
Alitretinoin—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00121	0.00215	CcSEcCtD
Alitretinoin—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00121	0.00214	CcSEcCtD
Alitretinoin—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00121	0.00214	CcSEcCtD
Alitretinoin—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00214	CcSEcCtD
Alitretinoin—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00214	CcSEcCtD
Alitretinoin—Alopecia—Colchicine—primary biliary cirrhosis	0.0012	0.00213	CcSEcCtD
Alitretinoin—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00212	CcSEcCtD
Alitretinoin—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00212	CcSEcCtD
Alitretinoin—Malnutrition—Colchicine—primary biliary cirrhosis	0.00118	0.0021	CcSEcCtD
Alitretinoin—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00118	0.00209	CcSEcCtD
Alitretinoin—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00118	0.00209	CcSEcCtD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.00115	0.00264	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.00115	0.00264	CbGpPWpGaD
Alitretinoin—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00203	CcSEcCtD
Alitretinoin—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00203	CcSEcCtD
Alitretinoin—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00202	CcSEcCtD
Alitretinoin—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00202	CcSEcCtD
Alitretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—primary biliary cirrhosis	0.00113	0.0026	CbGpPWpGaD
Alitretinoin—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00111	0.00197	CcSEcCtD
Alitretinoin—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00111	0.00197	CcSEcCtD
Alitretinoin—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.0011	0.00194	CcSEcCtD
Alitretinoin—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.0011	0.00194	CcSEcCtD
Alitretinoin—RXRA—The citric acid (TCA) cycle and respiratory electron transport—PDHX—primary biliary cirrhosis	0.00109	0.00251	CbGpPWpGaD
Alitretinoin—Anaemia—Colchicine—primary biliary cirrhosis	0.00109	0.00194	CcSEcCtD
Alitretinoin—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00109	0.00194	CcSEcCtD
Alitretinoin—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00109	0.00194	CcSEcCtD
Alitretinoin—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00108	0.00192	CcSEcCtD
Alitretinoin—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00108	0.00192	CcSEcCtD
Alitretinoin—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00106	0.00189	CcSEcCtD
Alitretinoin—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00106	0.00189	CcSEcCtD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.00106	0.00243	CbGpPWpGaD
Alitretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARGC1A—primary biliary cirrhosis	0.00106	0.00242	CbGpPWpGaD
Alitretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—PPARGC1A—primary biliary cirrhosis	0.00106	0.00242	CbGpPWpGaD
Alitretinoin—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00105	0.00186	CcSEcCtD
Alitretinoin—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00105	0.00186	CcSEcCtD
Alitretinoin—Tension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00104	0.00185	CcSEcCtD
Alitretinoin—Tension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00104	0.00185	CcSEcCtD
Alitretinoin—Nervousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00183	CcSEcCtD
Alitretinoin—Nervousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00183	CcSEcCtD
Alitretinoin—RXRA—The citric acid (TCA) cycle and respiratory electron transport—DLAT—primary biliary cirrhosis	0.00103	0.00236	CbGpPWpGaD
Alitretinoin—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00183	CcSEcCtD
Alitretinoin—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00183	CcSEcCtD
Alitretinoin—Myalgia—Colchicine—primary biliary cirrhosis	0.00101	0.00179	CcSEcCtD
Alitretinoin—Arthralgia—Colchicine—primary biliary cirrhosis	0.00101	0.00179	CcSEcCtD
Alitretinoin—CYP1A2—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.000993	0.00228	CbGpPWpGaD
Alitretinoin—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000987	0.00175	CcSEcCtD
Alitretinoin—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000987	0.00175	CcSEcCtD
Alitretinoin—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000983	0.00174	CcSEcCtD
Alitretinoin—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000983	0.00174	CcSEcCtD
Alitretinoin—RXRA—Transcriptional activation of mitochondrial biogenesis—PPARGC1A—primary biliary cirrhosis	0.000968	0.00222	CbGpPWpGaD
Alitretinoin—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.000959	0.0017	CcSEcCtD
Alitretinoin—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.000959	0.0017	CcSEcCtD
Alitretinoin—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.000954	0.00169	CcSEcCtD
Alitretinoin—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.000954	0.00169	CcSEcCtD
Alitretinoin—Shock—Colchicine—primary biliary cirrhosis	0.000951	0.00169	CcSEcCtD
Alitretinoin—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000947	0.00168	CcSEcCtD
Alitretinoin—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000946	0.00168	CcSEcCtD
Alitretinoin—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.00094	0.00167	CcSEcCtD
Alitretinoin—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.00094	0.00167	CcSEcCtD
Alitretinoin—Skin disorder—Colchicine—primary biliary cirrhosis	0.000938	0.00166	CcSEcCtD
Alitretinoin—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000935	0.00166	CcSEcCtD
Alitretinoin—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000935	0.00166	CcSEcCtD
Alitretinoin—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000928	0.00165	CcSEcCtD
Alitretinoin—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000928	0.00165	CcSEcCtD
Alitretinoin—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.000922	0.00163	CcSEcCtD
Alitretinoin—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.000922	0.00163	CcSEcCtD
Alitretinoin—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000918	0.00163	CcSEcCtD
Alitretinoin—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000918	0.00163	CcSEcCtD
Alitretinoin—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000915	0.0021	CbGpPWpGaD
Alitretinoin—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000906	0.00161	CcSEcCtD
Alitretinoin—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000906	0.00161	CcSEcCtD
Alitretinoin—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000906	0.00161	CcSEcCtD
Alitretinoin—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000906	0.00161	CcSEcCtD
Alitretinoin—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000906	0.00161	CcSEcCtD
Alitretinoin—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000906	0.00161	CcSEcCtD
Alitretinoin—Hypotension—Colchicine—primary biliary cirrhosis	0.000903	0.0016	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000899	0.0016	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000899	0.0016	CcSEcCtD
Alitretinoin—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000895	0.00159	CcSEcCtD
Alitretinoin—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000895	0.00159	CcSEcCtD
Alitretinoin—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.000886	0.00157	CcSEcCtD
Alitretinoin—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.000886	0.00157	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.00088	0.00156	CcSEcCtD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—primary biliary cirrhosis	0.000875	0.00201	CbGpPWpGaD
Alitretinoin—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.000875	0.00155	CcSEcCtD
Alitretinoin—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.000875	0.00155	CcSEcCtD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—RPS6KB1—primary biliary cirrhosis	0.000874	0.00201	CbGpPWpGaD
Alitretinoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000872	0.002	CbGpPWpGaD
Alitretinoin—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000868	0.00154	CcSEcCtD
Alitretinoin—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000868	0.00154	CcSEcCtD
Alitretinoin—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000862	0.00153	CcSEcCtD
Alitretinoin—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000862	0.00153	CcSEcCtD
Alitretinoin—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000854	0.00151	CcSEcCtD
Alitretinoin—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000854	0.00151	CcSEcCtD
Alitretinoin—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000851	0.00151	CcSEcCtD
Alitretinoin—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000851	0.00151	CcSEcCtD
Alitretinoin—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00085	0.00151	CcSEcCtD
Alitretinoin—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00085	0.00151	CcSEcCtD
Alitretinoin—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000847	0.0015	CcSEcCtD
Alitretinoin—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000847	0.0015	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—LBR—primary biliary cirrhosis	0.000846	0.00194	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—LBR—primary biliary cirrhosis	0.000846	0.00194	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—PPARGC1A—primary biliary cirrhosis	0.000846	0.00194	CbGpPWpGaD
Alitretinoin—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000843	0.0015	CcSEcCtD
Alitretinoin—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000843	0.0015	CcSEcCtD
Alitretinoin—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00084	0.00149	CcSEcCtD
Alitretinoin—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000839	0.00149	CcSEcCtD
Alitretinoin—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000839	0.00149	CcSEcCtD
Alitretinoin—RXRA—Mitochondrial biogenesis—PPARGC1A—primary biliary cirrhosis	0.000837	0.00192	CbGpPWpGaD
Alitretinoin—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000834	0.00148	CcSEcCtD
Alitretinoin—ABCB1—ABC-family proteins mediated transport—ABCC2—primary biliary cirrhosis	0.000833	0.00191	CbGpPWpGaD
Alitretinoin—Fatigue—Colchicine—primary biliary cirrhosis	0.000833	0.00148	CcSEcCtD
Alitretinoin—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000827	0.00147	CcSEcCtD
Alitretinoin—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000827	0.00147	CcSEcCtD
Alitretinoin—RXRA—Circadian Clock—PPARGC1A—primary biliary cirrhosis	0.000825	0.00189	CbGpPWpGaD
Alitretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—primary biliary cirrhosis	0.000822	0.00189	CbGpPWpGaD
Alitretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—primary biliary cirrhosis	0.000822	0.00189	CbGpPWpGaD
Alitretinoin—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000811	0.00144	CcSEcCtD
Alitretinoin—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000811	0.00144	CcSEcCtD
Alitretinoin—RARA—Adipogenesis—PPARGC1A—primary biliary cirrhosis	0.000795	0.00183	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.000791	0.00182	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000791	0.0014	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000791	0.0014	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.00079	0.0014	CcSEcCtD
Alitretinoin—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000785	0.00139	CcSEcCtD
Alitretinoin—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000785	0.00139	CcSEcCtD
Alitretinoin—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000779	0.00138	CcSEcCtD
Alitretinoin—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000779	0.00138	CcSEcCtD
Alitretinoin—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000774	0.00137	CcSEcCtD
Alitretinoin—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000774	0.00137	CcSEcCtD
Alitretinoin—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000772	0.00137	CcSEcCtD
Alitretinoin—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000772	0.00137	CcSEcCtD
Alitretinoin—Urticaria—Colchicine—primary biliary cirrhosis	0.000768	0.00136	CcSEcCtD
Alitretinoin—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000764	0.00136	CcSEcCtD
Alitretinoin—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000764	0.00136	CcSEcCtD
Alitretinoin—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000764	0.00135	CcSEcCtD
Alitretinoin—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000755	0.00134	CcSEcCtD
Alitretinoin—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000755	0.00134	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000749	0.00133	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000749	0.00133	CcSEcCtD
Alitretinoin—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000748	0.00133	CcSEcCtD
Alitretinoin—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000748	0.00133	CcSEcCtD
Alitretinoin—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000742	0.00132	CcSEcCtD
Alitretinoin—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000742	0.00132	CcSEcCtD
Alitretinoin—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000742	0.00132	CcSEcCtD
Alitretinoin—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000742	0.00132	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	0.000738	0.00169	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000715	0.00127	CcSEcCtD
Alitretinoin—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000715	0.00127	CcSEcCtD
Alitretinoin—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000712	0.00126	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00071	0.00126	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00071	0.00126	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	0.000707	0.00162	CbGpPWpGaD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000696	0.0016	CbGpPWpGaD
Alitretinoin—Asthenia—Colchicine—primary biliary cirrhosis	0.000693	0.00123	CcSEcCtD
Alitretinoin—CYP1A2—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000692	0.00159	CbGpPWpGaD
Alitretinoin—RXRA—Bile acid and bile salt metabolism—ALB—primary biliary cirrhosis	0.000692	0.00159	CbGpPWpGaD
Alitretinoin—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00069	0.00122	CcSEcCtD
Alitretinoin—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00069	0.00122	CcSEcCtD
Alitretinoin—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000686	0.00122	CcSEcCtD
Alitretinoin—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000686	0.00122	CcSEcCtD
Alitretinoin—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000686	0.00122	CcSEcCtD
Alitretinoin—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000686	0.00122	CcSEcCtD
Alitretinoin—RXRA—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.00068	0.00156	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—HIF1A—primary biliary cirrhosis	0.000661	0.00152	CbGpPWpGaD
Alitretinoin—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000661	0.00117	CcSEcCtD
Alitretinoin—RXRG—Adipogenesis—AGT—primary biliary cirrhosis	0.000659	0.00151	CbGpPWpGaD
Alitretinoin—RXRA—Circadian Clock—HIF1A—primary biliary cirrhosis	0.000645	0.00148	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00064	0.00113	CcSEcCtD
Alitretinoin—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00064	0.00113	CcSEcCtD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARGC1A—primary biliary cirrhosis	0.00063	0.00145	CbGpPWpGaD
Alitretinoin—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000623	0.0011	CcSEcCtD
Alitretinoin—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000623	0.0011	CcSEcCtD
Alitretinoin—RXRA—PPARA activates gene expression—CTGF—primary biliary cirrhosis	0.000622	0.00143	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—HIF1A—primary biliary cirrhosis	0.000622	0.00143	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—AGT—primary biliary cirrhosis	0.000619	0.00142	CbGpPWpGaD
Alitretinoin—Vomiting—Colchicine—primary biliary cirrhosis	0.000614	0.00109	CcSEcCtD
Alitretinoin—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000614	0.00109	CcSEcCtD
Alitretinoin—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000614	0.00109	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—primary biliary cirrhosis	0.000613	0.00141	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—OGDH—primary biliary cirrhosis	0.000612	0.0014	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—OGDH—primary biliary cirrhosis	0.000612	0.0014	CbGpPWpGaD
Alitretinoin—Rash—Colchicine—primary biliary cirrhosis	0.000609	0.00108	CcSEcCtD
Alitretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—primary biliary cirrhosis	0.000609	0.0014	CbGpPWpGaD
Alitretinoin—Dermatitis—Colchicine—primary biliary cirrhosis	0.000609	0.00108	CcSEcCtD
Alitretinoin—Headache—Colchicine—primary biliary cirrhosis	0.000605	0.00107	CcSEcCtD
Alitretinoin—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000594	0.00105	CcSEcCtD
Alitretinoin—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000594	0.00105	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000575	0.00132	CbGpPWpGaD
Alitretinoin—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00102	CcSEcCtD
Alitretinoin—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00102	CcSEcCtD
Alitretinoin—Nausea—Colchicine—primary biliary cirrhosis	0.000574	0.00102	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—CXCR5—primary biliary cirrhosis	0.000564	0.00129	CbGpPWpGaD
Alitretinoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—primary biliary cirrhosis	0.000554	0.00127	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	0.000552	0.00127	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	0.000552	0.00127	CbGpPWpGaD
Alitretinoin—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000552	0.000979	CcSEcCtD
Alitretinoin—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000552	0.000979	CcSEcCtD
Alitretinoin—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000547	0.000971	CcSEcCtD
Alitretinoin—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000547	0.000971	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000547	0.00126	CbGpPWpGaD
Alitretinoin—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000547	0.00097	CcSEcCtD
Alitretinoin—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000547	0.00097	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—PDHX—primary biliary cirrhosis	0.000545	0.00125	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PDHX—primary biliary cirrhosis	0.000545	0.00125	CbGpPWpGaD
Alitretinoin—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000544	0.000965	CcSEcCtD
Alitretinoin—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000544	0.000965	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IGFBP1—primary biliary cirrhosis	0.000521	0.0012	CbGpPWpGaD
Alitretinoin—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000516	0.000915	CcSEcCtD
Alitretinoin—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000516	0.000915	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—DLAT—primary biliary cirrhosis	0.000513	0.00118	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ABCB4—primary biliary cirrhosis	0.000513	0.00118	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—DLAT—primary biliary cirrhosis	0.000513	0.00118	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ABCB4—primary biliary cirrhosis	0.000513	0.00118	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CXCL9—primary biliary cirrhosis	0.000512	0.00118	CbGpPWpGaD
Alitretinoin—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000508	0.00117	CbGpPWpGaD
Alitretinoin—Acitretin—ALB—primary biliary cirrhosis	0.000498	1	CrCbGaD
Alitretinoin—ABCB1—Allograft Rejection—IL12A—primary biliary cirrhosis	0.000498	0.00114	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—primary biliary cirrhosis	0.000489	0.00112	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—RPS6KA4—primary biliary cirrhosis	0.000488	0.00112	CbGpPWpGaD
Alitretinoin—RXRA—PPARA activates gene expression—PPARGC1A—primary biliary cirrhosis	0.000474	0.00109	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	0.000472	0.00108	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	0.000472	0.00108	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARGC1A—primary biliary cirrhosis	0.000464	0.00106	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—CTGF—primary biliary cirrhosis	0.000444	0.00102	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—ABCG2—primary biliary cirrhosis	0.000436	0.001	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000424	0.000974	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	0.00042	0.000964	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	0.00042	0.000964	CbGpPWpGaD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—primary biliary cirrhosis	0.00042	0.000963	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—PPARGC1A—primary biliary cirrhosis	0.000414	0.000951	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—CTGF—primary biliary cirrhosis	0.000406	0.000931	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—CTGF—primary biliary cirrhosis	0.000398	0.000913	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—primary biliary cirrhosis	0.000385	0.000884	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—CTGF—primary biliary cirrhosis	0.000381	0.000875	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—CTGF—primary biliary cirrhosis	0.000381	0.000875	CbGpPWpGaD
Alitretinoin—RXRA—Organelle biogenesis and maintenance—PPARGC1A—primary biliary cirrhosis	0.00038	0.000872	CbGpPWpGaD
Alitretinoin—RXRA—Biological oxidations—GGT1—primary biliary cirrhosis	0.000372	0.000854	CbGpPWpGaD
Alitretinoin—RXRA—PPARA activates gene expression—AGT—primary biliary cirrhosis	0.000369	0.000847	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	0.000369	0.000846	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—primary biliary cirrhosis	0.000361	0.000829	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000349	0.0008	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	0.000327	0.000751	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	0.000327	0.000751	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—HIF1A—primary biliary cirrhosis	0.000324	0.000744	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—AGT—primary biliary cirrhosis	0.000323	0.000741	CbGpPWpGaD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARGC1A—primary biliary cirrhosis	0.000319	0.000733	CbGpPWpGaD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	0.000319	0.000732	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.000316	0.000726	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL12B—primary biliary cirrhosis	0.000313	0.000718	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—NUP210—primary biliary cirrhosis	0.000308	0.000707	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—NUP210—primary biliary cirrhosis	0.000308	0.000707	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CTLA4—primary biliary cirrhosis	0.000294	0.000675	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ABCG2—primary biliary cirrhosis	0.000287	0.000658	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ABCG2—primary biliary cirrhosis	0.000287	0.000658	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—NFKB1—primary biliary cirrhosis	0.000286	0.000656	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	0.000277	0.000635	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—NUP210—primary biliary cirrhosis	0.000268	0.000614	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	0.000265	0.000609	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—LBR—primary biliary cirrhosis	0.000256	0.000588	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	0.000251	0.000576	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	0.000251	0.000576	CbGpPWpGaD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—primary biliary cirrhosis	0.000249	0.000571	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CTGF—primary biliary cirrhosis	0.000246	0.000564	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CTGF—primary biliary cirrhosis	0.000246	0.000564	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—NUP210—primary biliary cirrhosis	0.000245	0.000562	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GOT2—primary biliary cirrhosis	0.000244	0.000559	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GOT2—primary biliary cirrhosis	0.000244	0.000559	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—NUP210—primary biliary cirrhosis	0.00024	0.000551	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—NUP210—primary biliary cirrhosis	0.00023	0.000528	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—NUP210—primary biliary cirrhosis	0.00023	0.000528	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CD40LG—primary biliary cirrhosis	0.000229	0.000525	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000227	0.000521	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—primary biliary cirrhosis	0.000223	0.000511	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL4—primary biliary cirrhosis	0.000223	0.000511	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000219	0.000502	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.000218	0.0005	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—CTGF—primary biliary cirrhosis	0.000214	0.00049	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GGT1—primary biliary cirrhosis	0.00021	0.000483	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GGT1—primary biliary cirrhosis	0.00021	0.000483	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GOT1—primary biliary cirrhosis	0.00021	0.000483	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GOT1—primary biliary cirrhosis	0.00021	0.000483	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase II conjugation—GGT1—primary biliary cirrhosis	0.000203	0.000466	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—NOS2—primary biliary cirrhosis	0.000203	0.000465	CbGpPWpGaD
Alitretinoin—CYP1A2—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	0.000199	0.000457	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000199	0.000457	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—CTGF—primary biliary cirrhosis	0.000199	0.000456	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—CTGF—primary biliary cirrhosis	0.000195	0.000448	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—CTGF—primary biliary cirrhosis	0.000192	0.00044	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PPARGC1A—primary biliary cirrhosis	0.000187	0.00043	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PPARGC1A—primary biliary cirrhosis	0.000187	0.00043	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—OGDH—primary biliary cirrhosis	0.000185	0.000425	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.000185	0.000425	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—CTGF—primary biliary cirrhosis	0.000184	0.000421	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—CTGF—primary biliary cirrhosis	0.000184	0.000421	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000184	0.000421	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CD80—primary biliary cirrhosis	0.00017	0.000391	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	0.000167	0.000383	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PDHX—primary biliary cirrhosis	0.000165	0.000379	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—DLAT—primary biliary cirrhosis	0.000155	0.000356	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ABCB4—primary biliary cirrhosis	0.000155	0.000356	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	0.000147	0.000338	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—AGT—primary biliary cirrhosis	0.000146	0.000335	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—AGT—primary biliary cirrhosis	0.000146	0.000335	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	0.000143	0.000328	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PPARGC1A—primary biliary cirrhosis	0.000142	0.000327	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	0.000138	0.000317	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—primary biliary cirrhosis	0.000138	0.000316	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	0.000127	0.000292	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NUP210—primary biliary cirrhosis	0.00012	0.000275	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—GGT1—primary biliary cirrhosis	0.000119	0.000273	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ALB—primary biliary cirrhosis	0.000112	0.000257	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ALB—primary biliary cirrhosis	0.000112	0.000257	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000111	0.000255	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—LBR—primary biliary cirrhosis	0.000102	0.000235	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	9.91e-05	0.000227	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—CTGF—primary biliary cirrhosis	9.57e-05	0.00022	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NUP210—primary biliary cirrhosis	9.33e-05	0.000214	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	9.08e-05	0.000208	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	8.7e-05	0.0002	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP2—primary biliary cirrhosis	8.69e-05	0.0002	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ABCG2—primary biliary cirrhosis	8.67e-05	0.000199	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TYK2—primary biliary cirrhosis	8.3e-05	0.00019	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—LBR—primary biliary cirrhosis	8.18e-05	0.000188	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	7.96e-05	0.000183	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	7.6e-05	0.000174	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CTGF—primary biliary cirrhosis	7.44e-05	0.000171	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—OGDH—primary biliary cirrhosis	7.4e-05	0.00017	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	7.4e-05	0.00017	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GOT2—primary biliary cirrhosis	7.38e-05	0.000169	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	7.23e-05	0.000166	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	6.6e-05	0.000151	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP9—primary biliary cirrhosis	6.53e-05	0.00015	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NFKB1—primary biliary cirrhosis	6.47e-05	0.000148	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GOT1—primary biliary cirrhosis	6.37e-05	0.000146	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GGT1—primary biliary cirrhosis	6.37e-05	0.000146	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	6.2e-05	0.000142	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	6.2e-05	0.000142	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—OGDH—primary biliary cirrhosis	5.91e-05	0.000136	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARGC1A—primary biliary cirrhosis	5.67e-05	0.00013	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	5.53e-05	0.000127	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	5.33e-05	0.000122	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PDHX—primary biliary cirrhosis	5.27e-05	0.000121	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—DLAT—primary biliary cirrhosis	4.95e-05	0.000114	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCB4—primary biliary cirrhosis	4.95e-05	0.000114	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	4.56e-05	0.000105	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AGT—primary biliary cirrhosis	4.41e-05	0.000101	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	4.06e-05	9.31e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	3.73e-05	8.56e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	3.47e-05	7.95e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALB—primary biliary cirrhosis	3.39e-05	7.77e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	3.16e-05	7.25e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NUP210—primary biliary cirrhosis	2.98e-05	6.83e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	2.97e-05	6.82e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	2.95e-05	6.76e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	2.89e-05	6.63e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCG2—primary biliary cirrhosis	2.77e-05	6.35e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	2.54e-05	5.84e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	2.54e-05	5.84e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	2.43e-05	5.57e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CTGF—primary biliary cirrhosis	2.37e-05	5.45e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GOT2—primary biliary cirrhosis	2.35e-05	5.4e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	2.26e-05	5.2e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GGT1—primary biliary cirrhosis	2.03e-05	4.66e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GOT1—primary biliary cirrhosis	2.03e-05	4.66e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARGC1A—primary biliary cirrhosis	1.81e-05	4.15e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AGT—primary biliary cirrhosis	1.76e-05	4.05e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AGT—primary biliary cirrhosis	1.41e-05	3.23e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALB—primary biliary cirrhosis	1.35e-05	3.11e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALB—primary biliary cirrhosis	1.08e-05	2.48e-05	CbGpPWpGaD
